Pictet Asset Management (UK)’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$267K Buy
210
+10
+5% +$11.3K ﹤0.01% 1486
2021
Q1
$219K Hold
200
﹤0.01% 1635
2020
Q4
$286K Buy
+200
New +$213K ﹤0.01% 1426

Other funds holding CDLX

Pictet Asset Management (UK)'s CDLX Position: Q2 2021 in Review

Pictet Asset Management (UK) increased its Cardlytics (CDLX) stake by 5% in Q2 2021, buying an estimated $11.3K and bringing the position to 210 shares worth $267K. The position accounts for ﹤0.01% of the portfolio, ranked #1486.

Pictet Asset Management (UK) first reported a position in CDLX in Q4 2020 and has held it in 3 quarters since. The position peaked at $286K in Q4 2020. 189 funds tracked by Wall St. Rank hold CDLX as of Q2 2021.

  • Pictet Asset Management (UK) held 210 shares of Cardlytics worth $267K as of Q2 2021.
  • Pictet Asset Management (UK) bought 10 Cardlytics shares in Q2 2021, an estimated $11.3K.
  • Cardlytics made up ﹤0.01% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #1486 holding.
  • Pictet Asset Management (UK) first reported a position in Cardlytics in Q4 2020 and has held it in 3 quarters since.
  • Pictet Asset Management (UK)'s Cardlytics position peaked at $286K in Q4 2020.
  • 189 funds tracked by Wall St. Rank held Cardlytics as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.